Riga, Latvia

Dzintra Muceniece



 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dzintra Muceniece: Innovator in Pharmaceutical Composition

Introduction

Dzintra Muceniece is a prominent inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and processes. With a total of 3 patents to her name, Muceniece has established herself as a key figure in her industry.

Latest Patents

One of her latest patents is titled "Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use." This invention relates to a pharmaceutical composition containing pimobendan as an active ingredient. It also introduces a crystalline form of pimobendan, along with a combination of this crystalline form with at least one other therapeutically active ingredient. Furthermore, the invention outlines the uses of the crystalline form and details a process for preparing it. Another notable invention provides an improved, highly efficient method for preparing 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole and its salts, particularly its pharmaceutically acceptable salts.

Career Highlights

Throughout her career, Muceniece has worked with reputable companies such as Fermion Oy and Eurovet Animal Health B.V. Her work has focused on advancing pharmaceutical technologies and improving therapeutic options for various medical conditions.

Collaborations

Muceniece has collaborated with notable professionals in her field, including Viesturs Lusis and Arne Grumann. These collaborations have contributed to her innovative research and development efforts.

Conclusion

Dzintra Muceniece is a trailblazer in the pharmaceutical industry, with a strong portfolio of patents that reflect her dedication to innovation. Her work continues to impact the field positively, paving the way for future advancements in pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…